Neuralstem

Neuralstem Rises on Publication of Alzheimer’s Stem Cell Therapy Data
Neuralstem Rises on Publication of Alzheimer’s Stem Cell Therapy Data
CP Wire
Neuralstem
NSI-532.IGF1
Alzheimer's disease
Flag link:
Neuralstem Rises on Publication of Alzheimer’s Stem Cell Therapy Data
Neuralstem
NSI-532.IGF1
Alzheimer's disease
Flag link:
FDA Grants Orphan Drug Designation to Neuralstem's Treatment for Angelman Syndrome
FDA Grants Orphan Drug Designation to Neuralstem's Treatment for Angelman Syndrome
CP Wire
Neuralstem
Angelman Syndrome
NSI-189
Flag link:
FDA Grants Orphan Drug Designation to Neuralstem's Treatment for Angelman Syndrome
Neuralstem
Flag link:
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Endpoints
Neuralstem
clinical trials
NSI-189
clinical depression
Flag link:
Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group
Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group
Yahoo
Neuralstem
Tianjin Pharmaceutical
R&D
China
Flag link:
Neuralstem to ax staff ‘across all divisions’ to save precious cash
Neuralstem to ax staff ‘across all divisions’ to save precious cash
Fierce Biotech
Neuralstem
layoffs
Flag link:
Neuralstem to Raise $1.08 Million
Neuralstem to Raise $1.08 Million
Yahoo
Neuralstem
Flag link:
Neuralstem reports 4Q loss
Neuralstem reports 4Q loss
Yahoo/AP
Neuralstem
earnings
Flag link:
Neuralstem posts second-quarter loss of $5.4 million
Neuralstem posts second-quarter loss of $5.4 million
Yahoo/AP
earnings
Neuralstem
Flag link:
Neuralstem reports 1Q loss
Neuralstem reports 1Q loss
Yahoo/AP
Neuralstem
earnings
Flag link:
Neuralstem tanks on cloudy results for its ALS treatment
Neuralstem tanks on cloudy results for its ALS treatment
Fierce Biotech
Neuralstem
ALS
NSI-566
Flag link:
3 Little-Known Biotech Stocks I'm Keeping an Eye On
3 Little-Known Biotech Stocks I'm Keeping an Eye On
Motley Fool
Neuralstem
Depomed
Xoma
Flag link:
Neuralstem Among Our 'Best for 2015' Biotech Names
Neuralstem Among Our 'Best for 2015' Biotech Names
Yahoo/Zacks
Neuralstem
Flag link:
Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs
Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs
Yahoo/Zacks
Neuralstem
Flag link:
Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs
Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs
Yahoo/Zacks.com
Neuralstem
NSI-566
Flag link:
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial
Yahoo
Neuralstem
ALS
stem cells
clinical trials
NSI-566
Flag link:
An Early Valuation Of Neuralstem's NSI-189 For MDD
An Early Valuation Of Neuralstem's NSI-189 For MDD
Seeking Alpha
Neuralstem
NSI-189
major depressive disorder
Flag link:
Neuralstem's Cell Therapy Is Working, And This Is Just The Beginning
Neuralstem's Cell Therapy Is Working, And This Is Just The Beginning
Seeking Alpha
Neuralstem
cell therapy
NSI-566
Flag link:
Why Neuralstem Inc. Shares Spiked Higher
Why Neuralstem Inc. Shares Spiked Higher
Motley Fool
Neuralstem
NSI-566
amyotrophic lateral sclerosis
stem cells
Flag link:

Pages